- Genmab (Plainsboro, NJ)
- …and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a ... proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+… more
- Genmab (Plainsboro, NJ)
- …and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a ... proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …appropriate communication tools for the various targeted audience to be leveraged in multi-channel communications (GBD Team All Hands meetings, internal stakeholder ... road shows, newsletters, annual impact report, organizational announcements, etc..)- Training and Development: Lead the development and roll out of a broader training and development program for GBD and extended members engaging in external innovation. This… more
- Genmab (Plainsboro, NJ)
- …and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a ... proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+… more
- Genmab (Plainsboro, NJ)
- …and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a ... proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+… more
- Genmab (Plainsboro, NJ)
- …and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a ... proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+… more
- Genmab (NJ)
- …and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a ... proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+… more
- Genmab (NJ)
- …and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a ... proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+… more
- Genmab (Plainsboro, NJ)
- …and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a ... proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+… more
- Genmab (Plainsboro, NJ)
- …and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a ... proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+… more
- Genmab (Plainsboro, NJ)
- …and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a ... proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+… more
- Genmab (Plainsboro, NJ)
- …and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a ... proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+… more
- Genmab (Plainsboro, NJ)
- …and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a ... proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+… more
- Genmab (Plainsboro, NJ)
- …and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a ... proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+… more
- Genmab (Plainsboro, NJ)
- …and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a ... proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+… more
- Genmab (Plainsboro, NJ)
- …and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a ... proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+… more
- Genmab (Plainsboro, NJ)
- …and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a ... proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+… more
- Genmab (NJ)
- …and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a ... proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+… more
- Genmab (Plainsboro, NJ)
- …and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a ... proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+… more
- Novo Nordisk Inc. (Plainsboro, NJ)
- …deliver critical business insights Defines and creates metrics that can be leveraged by CMR analysts to deliver insights to their stakeholders Oversees consultants ... and/or contractors as needed to deliver clinical and medical informatics software and systems tailored to meet the needs of customers and align with research objectives Serving as an internal expert on clinical informatics tools development in support of… more
Related Job Searches:
Associate Corporate Banking Leveraged,
Associate Investment Banking Leveraged,
Associate Leveraged Finance Middle,
Investment Banking Leveraged Finance,
Leveraged Finance,
Leveraged Finance Analyst,
Leveraged Finance Associate,
Leveraged Finance Credit Risk,
Risk Management Leveraged Finance,
Vice President Leveraged Finance